The Global Dementia Drugs Market is entering a more differentiated therapeutic phase as conventional symptomatic medicines increasingly coexist with disease-modifying approaches. The global market is witnessing growing attention toward therapeutic options designed to address the evolving needs associated with dementia. This changing treatment landscape is contributing to the expansion of the...